Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma

被引:0
作者
Chiharu Tabata
Eisuke Shibata
Rie Tabata
Shingo Kanemura
Koji Mikami
Yoshitaka Nogi
Eriko Masachika
Tomoyuki Nishizaki
Takashi Nakano
机构
[1] Hyogo College of Medicine,Division of Respiratory Medicine, Department of Internal Medicine
[2] Hyogo Prefectural Tsukaguchi Hospital,Department of Internal Medicine
[3] Hyogo College of Medicine,Division of Bioinformation, Department of Physiology
来源
BMC Cancer | / 13卷
关键词
Mesothelioma; Tumor marker; HMGB1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 211 条
[1]  
Robinson BW(2005)Malignant mesothelioma Lancet 366 397-408
[2]  
Musk AW(2005)Advances in malignant mesothelioma N Engl J Med 353 1591-1603
[3]  
Lake RA(1960)Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province Br J Ind Med 17 260-271
[4]  
Robinson BW(2003)Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma J Clin Oncol 21 2636-2644
[5]  
Lake RA(2002)New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents Semin Oncol 29 82-96
[6]  
Wagner JC(2003)Mesothelin-family proteins and diagnosis of mesothelioma Lancet 362 1612-1616
[7]  
Sleggs CA(2012)Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis J Clin Oncol 30 1541-1549
[8]  
Marchand P(1989)Specific recognition of cruciform DNA by nuclear protein HMG1 Science 243 1056-1059
[9]  
Vogelzang NJ(2002)Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 191-195
[10]  
Rusthoven JJ(2007)The role of the receptor for advanced glycation end-products in lung fibrosis Am J Physiol Lung Cell Mol Physiol 293 L1427-L1436